PCRX - Pacira BioSciences, Inc

Healthcare - Sector
Coverage Rating Distribution Performance Price Targets & Ratings Chart

PCRX is currently covered by 10 analysts with average potential upside of $12.5 (25.34%) backed by 232 price targets and 236 ratings. Documented since 09-Dec-2011. Analyst's average stock valuation to be materialised ratio is 77.1% with an average time for price targets to be met of 345.88 days.

Most recent stock forecast was given by OREN LIVNAT from HCWAINWRIGHT on 01-Mar-2023.

Highest price target for PCRX is 69, Lowest price target is 37, average price target is 53.

Currently, out of the existing stock ratings of PCRX - 29 which are a Buy (74.36%), 10 which are a Hold (25.64%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

71

$30.82 (76.70%)

69

30 days ago

9/17 (52.94%)

$16.87 (36.05%)

236

Buy

60

$19.82 (49.33%)

63

1 months 3 days ago

9/15 (60%)

$17.34 (37.22%)

291

Buy

60

$19.82 (49.33%)

94

2 months ago

3/19 (15.79%)

$39.74 (81.67%)

1358

Hold

52

$11.82 (29.42%)

60

2 months 25 days ago

25/28 (89.29%)

$1.94 (3.07%)

65

Buy

80

$39.82 (99.10%)

90

8 months 10 days ago

16/21 (76.19%)

$12.87 (26.89%)

391

Show more analysts

What is PCRX(Pacira BioSciences, Inc) average time for price targets to be met?

On average it took 345.88 days on average for the stock forecasts to be realized with a an average price target met ratio 77.1

Which analyst has the current highest performing score on PCRX(Pacira BioSciences, Inc) with a proven track record?

LIANA MOUSSATOS